SAGE Therapeutics (SAGE), Biogen (BIIB) to Submit NDA for Zuranolone to FDA in Second Half of 2022 with Rolling Submission Expected to Start in Early 2022

Go back to SAGE Therapeutics (SAGE), Biogen (BIIB) to Submit NDA for Zuranolone to FDA in Second Half of 2022 with Rolling Submission Expected to Start in Early 2022
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 218.30 -2.22 (1.01%)
Previous Close $220.52    52 Week High $333.65 
Open $220.22    52 Week Low $223.02 
Day High $222.04    P/E 27.95 
Day Low $214.88    EPS $7.81 
Volume 771,616       

Sagebrush Gold Ltd. (NASDAQ: SAGE) Delayed: 36.38 -1.83 (4.79%)
Previous Close $38.21    52 Week High $62.64 
Open $37.33    52 Week Low $26.28 
Day High $37.92    P/E N/A 
Day Low $36.02    EPS $-0.94 
Volume 367,965